Richmond Pharmacology is pleased to announce our attendance at ESC Congress 2025, the European Society of Cardiology’s flagship event, held in Madrid from 29thAugust– 1st September.

Representing Richmond Pharmacology at ESC Congress:

  • Dr Jörg Täubel, Chief Executive Officer

DrTäubel looks forward to connecting with clinicians, researchers, and industryleaders, sharing Richmond’s expertise in:

  • Early-phase cardiovascular and cardiometabolic trials
  • Novel endpoints and digital health integration
  • Risk-stratified study design and cardiac safety
  • Accelerated CV drug development pathways
  • Patient-focused recruitment and retention

If you’re attending ESC 2025 and seeking an expert partner for cardiovascular clinical trials, we welcome meeting requests at: info@richmondpharmacology.com

Learn more: ESC2025 | ESC 2025 Registration | ESC Annual Congress 2025

‍

Latest news

Leadership Spotlight - Head of Pharmacovigilance

November 16, 2026
Amina Ghareeb on Building Richmond's Pharmacovigilance Expertise
Read more

Upcoming Event

JSCPT 2026

27 - 28 November 2026
Richmond Pharmacology is excited to join the JSCPT Annual Meeting 2026 in Tokyo, Japan, on 27-28 November 2026.
View event